FR2468373A1 - Solvant parenteral et procede de preparation de solutions stables qui les contiennent - Google Patents

Solvant parenteral et procede de preparation de solutions stables qui les contiennent Download PDF

Info

Publication number
FR2468373A1
FR2468373A1 FR8023347A FR8023347A FR2468373A1 FR 2468373 A1 FR2468373 A1 FR 2468373A1 FR 8023347 A FR8023347 A FR 8023347A FR 8023347 A FR8023347 A FR 8023347A FR 2468373 A1 FR2468373 A1 FR 2468373A1
Authority
FR
France
Prior art keywords
hydroxy
general formula
hydrogen
water
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8023347A
Other languages
English (en)
French (fr)
Other versions
FR2468373B1 (OSRAM
Inventor
Geza Takacsi Nagy
Gabor Szepesi
Maria Gazdag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Nyrt
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt, Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Nyrt
Publication of FR2468373A1 publication Critical patent/FR2468373A1/fr
Application granted granted Critical
Publication of FR2468373B1 publication Critical patent/FR2468373B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8023347A 1979-11-02 1980-10-31 Solvant parenteral et procede de preparation de solutions stables qui les contiennent Granted FR2468373A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application

Publications (2)

Publication Number Publication Date
FR2468373A1 true FR2468373A1 (fr) 1981-05-08
FR2468373B1 FR2468373B1 (OSRAM) 1984-12-28

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8023347A Granted FR2468373A1 (fr) 1979-11-02 1980-10-31 Solvant parenteral et procede de preparation de solutions stables qui les contiennent

Country Status (24)

Country Link
US (1) US4344950A (OSRAM)
JP (1) JPS56123911A (OSRAM)
AR (1) AR223735A1 (OSRAM)
AT (1) AT377914B (OSRAM)
AU (1) AU533715B2 (OSRAM)
BE (1) BE885987A (OSRAM)
CA (1) CA1159367A (OSRAM)
CH (1) CH645019A5 (OSRAM)
CS (1) CS226417B2 (OSRAM)
DD (1) DD153760A5 (OSRAM)
DE (1) DE3041368A1 (OSRAM)
DK (1) DK464680A (OSRAM)
FI (1) FI803401L (OSRAM)
FR (1) FR2468373A1 (OSRAM)
GB (1) GB2062464B (OSRAM)
HU (1) HU181940B (OSRAM)
IL (1) IL61310A (OSRAM)
IT (1) IT1209367B (OSRAM)
NL (1) NL8005980A (OSRAM)
NO (1) NO803254L (OSRAM)
PH (1) PH17037A (OSRAM)
SE (1) SE8007569L (OSRAM)
YU (1) YU278880A (OSRAM)
ZA (1) ZA806468B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891A1 (OSRAM) * 1972-07-13 1974-02-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891A1 (OSRAM) * 1972-07-13 1974-02-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
CS226417B2 (en) 1984-03-19
IL61310A0 (en) 1980-12-31
GB2062464A (en) 1981-05-28
DK464680A (da) 1981-05-03
ZA806468B (en) 1981-10-28
BE885987A (fr) 1981-02-16
FI803401A7 (fi) 1981-05-03
IT8025683A0 (it) 1980-10-31
CH645019A5 (de) 1984-09-14
SE8007569L (sv) 1981-05-03
HU181940B (en) 1983-11-28
JPS56123911A (en) 1981-09-29
IL61310A (en) 1984-08-31
DD153760A5 (de) 1982-02-03
FI803401L (fi) 1981-05-03
PH17037A (en) 1984-05-17
US4344950A (en) 1982-08-17
YU278880A (en) 1984-04-30
AR223735A1 (es) 1981-09-15
FR2468373B1 (OSRAM) 1984-12-28
AT377914B (de) 1985-05-28
GB2062464B (en) 1983-12-07
CA1159367A (en) 1983-12-27
NL8005980A (nl) 1981-06-01
NO803254L (no) 1981-05-04
ATA527980A (de) 1984-10-15
DE3041368A1 (de) 1981-05-14
AU6400480A (en) 1981-05-07
IT1209367B (it) 1989-07-16
AU533715B2 (en) 1983-12-08

Similar Documents

Publication Publication Date Title
CA2150576C (fr) Compositions injectables a base de derives des taxanes
SK279946B6 (sk) Farmaceutická kompozícia, spôsob jej prípravy a in
US4855307A (en) Acetic acid ester of haloperidol
CH652931A5 (fr) Composition adjuvante pour aider l'absorption d'une substance pharmacologiquement active, administree par l'intermediaire de l'appareil digestif.
US5284873A (en) Pharmaceutical compositions derived from the acid fraction of lipid extracts of sabal serrulata, with adrenergic antagonist activity and method of preparing said composition
FR2468373A1 (fr) Solvant parenteral et procede de preparation de solutions stables qui les contiennent
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
CA1240326A (en) 2-(.omega.-ALKYLAMINOALKYL)-AND 2-(.omega.-DIALKYLAMINOALKYL)- 3-(4-X-BENZYLIDEN)-PHTALIMIDINES
EP0113330B1 (fr) Composés énamides acylés, compositions pharmaceutiques les contenant, utilisation de ces composés et procédé de préparation de ces composés
FR2459658A1 (fr) Procede de preparation d'une composition pharmaceutique a base de methoxsalen administrable par voie orale
EP0117171B1 (fr) Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant
EP0209511B1 (fr) Chlorhydrates de chlorures de dérivés d'aminoalkyl-2 hydroxy-9 ellipticinium et compositions pharmaceutiques en contenant
US4201866A (en) O-Hemi-succinate of propranolol
SU1544191A3 (ru) Способ получени производных пиримидо/2,1- @ /бензотиазола
EP0034521B1 (fr) Médicament analgésique contenant de la 1-(3'benzofuryl)-4-benzylpipérazine et son procédé de préparation
EP0300107A1 (fr) Nouveaux dérivés ester, thioester et amide de l'acide oxolinique, leur procédé de préparation et leur application en thérapeutique
EP0008269A1 (fr) Nouveaux médicaments contenant, à titre de substance active, des composés de type benzènesulfone, nouveaux composés de ce type et procédé pour leur préparation
EP0185066A1 (OSRAM)
LU85212A1 (fr) Nouveaux derives de l'acide lysergique,leur preparation et leur utilisation comme medicaments
FR2499571A1 (fr) Nouveaux derives d'apovincaminol, leur preparation et leur application en tant que medicaments
US2979525A (en) New crystalline pantothenic acid ester and process for the production thereof
FR2597341A1 (fr) Solution pharmaceutique contenant de chelates de l-3,4-dihydroxyphenyl-alpha-methylalanine et procede pour la preparation de celle-ci.
FR2504141A1 (fr) Nouveaux derives dioxazabicycliques, leur procede de preparation et leur application en therapeutique
FR2637287A1 (fr) Esters de l'hydroxy-2((pyrrolidinyl-1)-2 ethoxy)-5 p-cymene, le procede de preparation desdits produits, et les medicaments contenant lesdits composes comme principe actif
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant

Legal Events

Date Code Title Description
ST Notification of lapse